Cleveland Cavaliers Sell Stake At $5.5B Valuation, NHL Expansion Into Texas, Meta & UFC Launch AI Ranking System ...
Steam Next Fest June 2026 — the largest edition of Valve's recurring free-demo event in its history — closes Monday, June 22, at 1:00 PM ET, leaving PC gamers two days to download and play thousands ...
Artificial intelligence technologies are advancing the ability to conduct proactive screening to catch the warning signs of serious health conditions, like heart disease. With earlier detection of ...
A months-long joint investigation by Consumer Reports and Groundwork Collaborative has uncovered widespread price testing on Instacart's grocery delivery platform. The research shows that identical ...
Background: Congenital heart disease (CHD) is the most common congenital anomaly, affecting 8–10 per 1,000 live births globally, and is a leading cause of perinatal morbidity and mortality. Despite ...
Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated history of working in both institutional and retail environments, from broker-dealers to ...
Abstract: Current internet environment has demanded the need for cloud computing technology in handling large information. The paper’s central theme is to evaluate the effectiveness of resources in ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. We present an ...
Abstract: In this article, we aim to offer an interpretable learning paradigm for incremental random weight neural networks (IRWNNs). IRWNNs have become a hot research direction of neural network ...
Noninvasive human-machine interfaces such as surface electromyography (sEMG) have long been employed for controlling robotic prostheses. However, classical controllers are limited to few degrees of ...
Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy. In this trial, we assessed whether omalizumab, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results